The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of consolidation nivolumab or nivolumab plus ipilimumab following concurrent chemoradiation in unresectable stage III NSCLC: BTCRC LUN16-081.
 
Greg Andrew Durm
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Susan M. Perkins
No Relationships to Disclose
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst)